ALEXANDER ROBINWEILER: Open Payments
NPI 1336574607 · BELLEVUE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 6 payments from 6 companies in 2025. Trend: 2023 $250 · 2024 $671 · 2025 $661
Food & beverage: $626Education: $35
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $147 |
| BeOne Medicines USA, Inc. | 1 | $137 |
| Pharmacosmos Therapeutics Inc. | 1 | $129 |
| Tempus AI, Inc | 1 | $106 |
| E.R. Squibb & Sons, L.L.C. | 1 | $106 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
Products named: RYBREVANT, TEVIMBRA, COSELA, XT CDX, OPDIVO, IMFINZI.
Industry payments across WA — which companies pay providers there.
